共有 50 笔近期内部人交易记录记录，涉及 Monte Rosa Therapeutics, Inc. (GLUE), 包括 29 笔买入 和 20 笔卖出. 内部人买入总额为 $8.8M 内部人卖出总额为 $11.95M.
近期活跃的重要内部人包括 Dunn Edmund, Warmuth Markus, Janku Filip. 内部人交易记录可以揭示公司管理层对股票估值和未来前景的看法.
内部人交易记录 — GLUE
| 日期 |
姓名 |
职位 |
交易类型 |
股数 |
平均价格 |
总价值 |
持股数量 |
| 2026-03-04 |
Dunn Edmund |
Principal Accounting Officer |
知情卖出 |
139 |
$17.96 |
$2.5K |
22,554 |
| 2026-03-02 |
Dunn Edmund |
Principal Accounting Officer |
期权行权（卖出） |
536 |
$13.41 |
$7.19K |
- |
| 2026-03-02 |
Warmuth Markus |
President & CEO |
知情卖出 |
5,466 |
$17.92 |
$97.97K |
613,471 |
| 2026-02-27 |
Dunn Edmund |
Principal Accounting Officer |
期权行权（卖出） |
25,164 |
$13.41 |
$337.45K |
536 |
| 2026-02-23 |
Janku Filip |
Chief Medical Officer |
知情卖出 |
9,189 |
$19.50 |
$179.16K |
65,837 |
| 2026-01-07 |
Warmuth Markus |
President & CEO |
知情卖出 |
309 |
$24.57 |
$7.59K |
618,937 |
| 2026-01-05 |
Warmuth Markus |
President & CEO |
知情卖出 |
10,135 |
$15.17 |
$153.75K |
624,403 |
| 2026-01-05 |
Townson Sharon |
Chief Scientific Officer |
知情卖出 |
3,155 |
$15.17 |
$47.86K |
67,845 |
| 2026-01-05 |
Janku Filip |
Chief Medical Officer |
知情卖出 |
3,155 |
$15.17 |
$47.86K |
75,026 |
| 2026-01-05 |
Nickson Philip |
Chief Business & Legal Officer |
知情卖出 |
3,155 |
$15.17 |
$47.86K |
60,845 |
| 2026-01-05 |
Dunn Edmund |
Principal Accounting Officer |
知情卖出 |
1,039 |
$15.17 |
$15.76K |
22,693 |
| 2026-01-05 |
Champoux Jennifer |
Chief Operating Officer |
知情卖出 |
2,629 |
$15.17 |
$39.88K |
62,371 |
| 2026-01-02 |
Warmuth Markus |
President & CEO |
限制性股票授予 (RSU) |
406,000 |
$15.31 |
$6.22M |
406,000 |
| 2026-01-02 |
Townson Sharon |
Chief Scientific Officer |
限制性股票授予 (RSU) |
35,000 |
- |
- |
71,000 |
| 2026-01-02 |
Janku Filip |
Chief Medical Officer |
限制性股票授予 (RSU) |
31,000 |
- |
- |
78,181 |
| 2026-01-02 |
Nickson Philip |
Chief Business & Legal Officer |
限制性股票授予 (RSU) |
28,000 |
- |
- |
64,000 |
| 2026-01-02 |
Champoux Jennifer |
Chief Operating Officer |
限制性股票授予 (RSU) |
35,000 |
- |
- |
65,000 |
| 2025-06-13 |
Schiff Andrew N |
Director |
限制性股票授予 (RSU) |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Behbahani Ali |
10 Percent Owner |
限制性股票授予 (RSU) |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Manning Anthony M. |
Director |
限制性股票授予 (RSU) |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Siu Christine |
Director |
限制性股票授予 (RSU) |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Blackwell Kimberly |
Director |
限制性股票授予 (RSU) |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Skvarka Jan |
Director |
限制性股票授予 (RSU) |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-13 |
Hughes Eric A |
Director |
限制性股票授予 (RSU) |
30,700 |
$4.91 |
$150.74K |
30,700 |
| 2025-06-03 |
Dunn Edmund |
Principal Accounting Officer |
知情卖出 |
2,062 |
$4.45 |
$9.17K |
23,732 |
| 2025-03-24 |
Leo Chandra P. |
Director |
知情买入 |
10,000 |
$5.84 |
$58.38K |
10,000 |
| 2025-01-02 |
Warmuth Markus |
President & CEO |
限制性股票授予 (RSU) |
128,000 |
- |
- |
544,538 |
| 2025-01-02 |
Townson Sharon |
Chief Scientific Officer |
限制性股票授予 (RSU) |
36,000 |
- |
- |
36,000 |
| 2025-01-02 |
Janku Filip |
Chief Medical Officer |
限制性股票授予 (RSU) |
36,000 |
- |
- |
45,189 |
| 2025-01-02 |
Nickson Philip |
Chief Business & Legal Officer |
限制性股票授予 (RSU) |
36,000 |
- |
- |
36,000 |
| 2025-01-02 |
Dunn Edmund |
Principal Accounting Officer |
限制性股票授予 (RSU) |
11,850 |
- |
- |
25,794 |
| 2025-01-02 |
Champoux Jennifer |
Chief Operating Officer |
限制性股票授予 (RSU) |
30,000 |
- |
- |
30,000 |
| 2024-12-11 |
Hughes Eric A |
Officer |
未知 |
- |
- |
- |
- |
| 2024-12-11 |
Hughes Eric A |
Director |
限制性股票授予 (RSU) |
44,200 |
$8.51 |
$376.14K |
44,200 |
| 2024-10-29 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
知情卖出 |
15,600 |
$9.41 |
$146.79K |
1,573,453 |
| 2024-10-28 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
其他（卖出） |
5,454 |
- |
- |
- |
| 2024-09-20 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
知情卖出 |
1,132,566 |
$6.53 |
$7.4M |
5,099,336 |
| 2024-09-13 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
知情卖出 |
9,269 |
$6.16 |
$57.1K |
6,231,902 |
| 2024-09-13 |
Janku Filip |
Chief Medical Officer |
限制性股票授予 (RSU) |
30,000 |
$7.56 |
$226.8K |
30,000 |
| 2024-09-12 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
知情卖出 |
16,047 |
$6.00 |
$96.31K |
6,241,171 |
| 2024-09-11 |
Versant Venture Capital Vi, L.p. |
10 Percent Owner |
知情卖出 |
541,897 |
$6.00 |
$3.25M |
6,257,218 |
| 2024-07-05 |
Dunn Edmund |
Principal Accounting Officer |
知情卖出 |
1,610 |
$3.83 |
$6.17K |
13,944 |
| 2024-06-12 |
Schiff Andrew N |
Director |
限制性股票授予 (RSU) |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Behbahani Ali |
10 Percent Owner |
限制性股票授予 (RSU) |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Manning Anthony M. |
Director |
限制性股票授予 (RSU) |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Siu Christine |
Director |
限制性股票授予 (RSU) |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Blackwell Kimberly |
Director |
限制性股票授予 (RSU) |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-12 |
Skvarka Jan |
Director |
限制性股票授予 (RSU) |
22,100 |
$4.16 |
$91.94K |
22,100 |
| 2024-06-03 |
Townson Sharon |
Chief Scientific Officer |
限制性股票授予 (RSU) |
40,000 |
$3.98 |
$159.2K |
40,000 |
| 2024-06-03 |
Nickson Philip |
Chief Business & Legal Officer |
限制性股票授予 (RSU) |
40,000 |
$3.98 |
$159.2K |
40,000 |
■ 知情交易 — 公开市场买卖（最具参考价值）
■ 非知情买入 — 奖励、期权行权、转换
■ 非知情卖出 — 税务代扣、归属出售
■ 中性 — 礼赠、信托、到期
